Antibodies are Y-shaped proteins composed of two heavy chains and two light chains, with variable domains (Fab) mediating antigen binding and constant domains (Fc) facilitating immune system interactions . Their primary functions include neutralizing pathogens, facilitating phagocytosis, and recruiting immune effector cells. SPBC800.10c, like other antibodies, would likely target a specific antigen, such as a viral protein or tumor marker, via its paratope (binding site).
Modern antibody engineering often employs computational platforms to optimize binding affinity and epitope targeting, as demonstrated in SARS-CoV-2 neutralizing antibodies . For example, the CR3022 antibody targets a non-ACE2-binding epitope on the viral spike protein, enabling combination therapies to prevent resistance . If SPBC800.10c follows similar approaches, its design might prioritize cross-reactivity or multi-specificity to broaden therapeutic applications.
Antibodies neutralize pathogens by blocking critical interactions, such as viral entry or enzymatic activity. For instance, the WRAIR-2125 antibody neutralizes all major SARS-CoV-2 variants by targeting a conserved epitope on the receptor-binding domain (RBD) . SPBC800.10c’s mechanism would depend on its antigen target, but successful neutralization typically requires high-affinity binding and epitope conservation across variants.
Experimental monoclonal antibodies, such as those targeting Epstein-Barr virus (EBV) glycoproteins gH/gL, have shown promise in preclinical studies by blocking viral fusion and providing prophylactic protection . If SPBC800.10c targets a similar viral or oncogenic antigen, its efficacy would depend on in vivo stability, half-life extension, and lack of immunogenicity. The inclusion of Fc modifications (e.g., NNAS mutations) could enhance therapeutic profiles .
Antibody resistance and viral escape mutations pose significant hurdles, as observed with SARS-CoV-2 spike variants . Effective antibodies often require epitope redundancy or multi-specific binding to mitigate resistance. For SPBC800.10c, robust epitope characterization and combination therapies would be critical to ensuring long-term efficacy.
KEGG: spo:SPBC800.10c
STRING: 4896.SPBC800.10c.1
SPBC800.10c is a protein found in Schizosaccharomyces pombe (fission yeast), with UniProt accession number Q9HGL2. While specific detailed functions are still being characterized, it appears to be related to chromatin regulation pathways in S. pombe. Chromatin regulators in S. pombe, such as Abo1 and HIRA, have been identified as regulators of various cellular processes including nitrogen-starvation induced quiescence . The SPBC800.10c protein likely functions within this broader context of chromatin regulation, potentially influencing gene expression, DNA replication, or DNA repair mechanisms. Understanding its exact role requires experimental validation using techniques such as chromatin immunoprecipitation (ChIP), gene knockout studies, and protein-protein interaction analyses.
The SPBC800.10c antibody has been validated for specific research applications including:
Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative detection of the SPBC800.10c protein in sample preparations
Western Blotting (WB) - For identification of the SPBC800.10c protein in cell or tissue lysates
When using these applications, researchers should follow standardized protocols for immunodetection techniques. For Western blotting, typical procedures involve sample preparation with appropriate lysis buffers, protein denaturation with SDS sample buffer, gel electrophoresis, transfer to PVDF membranes, blocking, and incubation with the primary SPBC800.10c antibody followed by detection with an appropriate secondary antibody system .
The SPBC800.10c antibody should be stored at -20°C or -80°C upon receipt. Researchers should avoid repeated freeze-thaw cycles to maintain antibody integrity and activity. The antibody is supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as a preservative .
For long-term storage, aliquoting the antibody into smaller volumes is recommended to minimize freeze-thaw cycles. When handling the antibody, use sterile techniques and keep on ice when in use. For optimal performance in experimental applications, always follow the manufacturer's recommendations for antibody dilutions and incubation conditions.
When optimizing the SPBC800.10c antibody for Western blotting, a systematic approach to dilution testing is essential. Begin with a range of antibody dilutions (typically 1:500 to 1:5000) to determine the optimal concentration that provides the best signal-to-noise ratio.
Optimization protocol:
Prepare identical Western blot membranes with your samples and positive controls
Block all membranes using the same blocking solution (typically 5% non-fat dry milk or BSA in TBST)
Incubate separate membranes with different dilutions of the SPBC800.10c antibody
Process all membranes identically for secondary antibody incubation and detection
Compare results to identify the dilution that provides specific binding with minimal background
Additionally, optimize exposure times during detection to avoid oversaturation of signals. The optimal antibody dilution may vary depending on sample type, protein abundance, and detection method used (chemiluminescence, fluorescence, etc.) .
Proper experimental controls are crucial for reliable interpretation of results when using the SPBC800.10c antibody:
Essential controls include:
Positive control: Lysate from wild-type S. pombe (strain 972/ATCC 24843) expressing normal levels of SPBC800.10c protein
Negative control: Lysate from S. pombe with SPBC800.10c deletion or knockdown, if available
Secondary antibody-only control: Samples processed without primary antibody to assess non-specific binding of the secondary antibody
Loading control: Detection of a housekeeping protein (e.g., actin or tubulin) to ensure equal loading across samples
Peptide competition assay: Pre-incubation of the antibody with excess purified SPBC800.10c protein or peptide to confirm antibody specificity
These controls help distinguish specific signals from background noise and validate the authenticity of observed results. Document all control results alongside experimental data for comprehensive interpretation and troubleshooting.
While ChIP is not explicitly listed among the validated applications for this antibody, researchers interested in exploring SPBC800.10c's interactions with chromatin could adapt standard ChIP protocols:
Cross-linking: Treat S. pombe cells with 1% formaldehyde for 10-15 minutes to cross-link protein-DNA interactions
Cell lysis and sonication: Lyse cells and sonicate to shear chromatin to fragments of approximately 200-500 bp
Pre-clearing: Incubate chromatin with protein A/G beads and non-immune serum to reduce non-specific binding
Immunoprecipitation: Incubate pre-cleared chromatin with the SPBC800.10c antibody (typically 2-5 μg per immunoprecipitation) overnight at 4°C
Washing and elution: Collect antibody-protein-DNA complexes using protein A/G beads, wash extensively, and elute
Reverse cross-linking: Incubate samples at 65°C overnight to reverse formaldehyde cross-links
DNA purification: Extract and purify DNA for subsequent analysis by qPCR or sequencing
If adapting this antibody for ChIP applications, thorough validation is necessary, including ChIP-qPCR of known targets or regions where SPBC800.10c is expected to bind.
Effective sample preparation is critical for successful detection of SPBC800.10c:
Cell harvesting: Collect cells during the appropriate growth phase, considering that protein expression may vary with cell cycle or environmental conditions
Lysis method selection:
For Western blotting: Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitor cocktail
For ELISA: Use milder lysis conditions that maintain native protein structure
Mechanical disruption: S. pombe has a tough cell wall; use glass beads and vortexing or a cell disruptor for efficient lysis
Clearing lysates: Centrifuge at 12,000-15,000g for 10-15 minutes at 4°C to remove cell debris
Protein quantification: Perform Bradford or BCA assay to standardize protein concentrations
Sample preparation: For Western blotting, mix samples with SDS sample buffer and heat at 100°C for 5 minutes
Prepare fresh lysates whenever possible, and if storage is necessary, add glycerol to a final concentration of 10-20% and store at -80°C to preserve protein integrity.
Investigating SPBC800.10c's potential role in nitrogen-starvation induced quiescence requires a comparative approach with known regulators like HIRA:
Growth condition experiments:
Culture wild-type and SPBC800.10c-deficient S. pombe strains in nitrogen-rich and nitrogen-depleted media
Monitor viability, cellular morphology, and quiescence entry/exit dynamics
Chromatin state analysis:
Perform ChIP-seq using the SPBC800.10c antibody under normal and nitrogen-starved conditions
Compare binding profiles with those of known quiescence regulators like HIRA
Transcriptome analysis:
Conduct RNA-seq comparing wild-type and SPBC800.10c-deficient strains during nitrogen starvation
Identify differentially expressed genes and compare with known quiescence-related gene signatures
Genetic interaction studies:
Analysis should focus on identifying genes or chromatin regions that show differential regulation dependent on SPBC800.10c during nitrogen starvation, potentially indicating a role in quiescence regulation.
Characterizing post-translational modifications (PTMs) of SPBC800.10c requires specialized techniques:
Immunoprecipitation and mass spectrometry workflow:
Immunoprecipitate SPBC800.10c using the antibody from S. pombe lysates
Separate proteins by SDS-PAGE and excise the band corresponding to SPBC800.10c
Perform in-gel digestion with trypsin or other proteases
Analyze peptides by liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Search for common PTMs such as phosphorylation, acetylation, methylation, SUMOylation, or ubiquitination
PTM-specific detection methods:
Use phospho-specific stains (e.g., Pro-Q Diamond) to detect phosphorylation
Employ PTM-specific antibodies in Western blots after immunoprecipitation with SPBC800.10c antibody
Use ELISA to quantify specific PTMs on immunoprecipitated SPBC800.10c
Functional validation:
Create S. pombe strains with mutations at PTM sites (e.g., S to A for phosphorylation sites)
Compare phenotypes of mutant strains with wild-type to assess functional significance of PTMs
Correlation of PTM patterns with cellular conditions or stress responses may provide insights into regulation mechanisms of SPBC800.10c function.
Understanding SPBC800.10c's protein interaction network can provide valuable insights into its function:
Co-immunoprecipitation (Co-IP):
Lyse S. pombe cells under non-denaturing conditions
Immunoprecipitate SPBC800.10c using the antibody
Analyze co-precipitated proteins by mass spectrometry or Western blotting with antibodies against suspected interaction partners
Validate interactions with reciprocal Co-IP experiments
Proximity-based labeling:
Create fusion proteins of SPBC800.10c with BioID or APEX2
Express in S. pombe and activate the labeling enzyme
Purify biotinylated proteins and identify by mass spectrometry
Yeast two-hybrid screening:
Document interaction conditions carefully, as some interactions may be transient, cell cycle-dependent, or occur only under specific stress conditions.
Polyclonal antibodies present specific challenges that require careful experimental design:
| Challenge | Cause | Solution |
|---|---|---|
| Batch-to-batch variability | Different immunized animals produce different antibody mixtures | Purchase sufficient quantity from single batch for long-term projects; validate each new batch |
| Cross-reactivity | Antibodies recognizing epitopes present on multiple proteins | Perform peptide competition assays; validate specificity with knockout controls |
| Variable sensitivity | Different epitopes recognized with different affinities | Optimize antibody concentration for each application; consider enriching target protein when possible |
| Background noise | Non-specific binding to sample components | Use more stringent washing steps; optimize blocking conditions; try different blocking agents |
| False positives | Recognition of similar epitopes on other proteins | Confirm results with alternative detection methods or second antibody against different epitope |
When interpreting results, always consider these potential limitations and include appropriate controls to distinguish genuine signals from artifacts .
Discrepancies between ELISA and Western blot results are common and may reflect biological or methodological differences:
Possible causes and interpretations:
Epitope accessibility:
ELISA often uses native protein conformations while Western blot uses denatured proteins
Different epitopes may be accessible in each method
Solution: Try native PAGE Western blot to maintain protein folding
Sensitivity differences:
ELISA typically has higher sensitivity than Western blot
Low abundance proteins may be detectable by ELISA but not Western blot
Solution: Enrich target protein by immunoprecipitation before Western blot
Cross-reactivity profiles:
ELISA may detect cross-reactive proteins that run at different molecular weights in Western blot
Solution: Use peptide competition assays in both techniques to confirm specificity
Post-translational modifications:
Different PTMs may affect antibody recognition differently in each technique
Solution: Use phosphatase or other enzyme treatments to remove PTMs before analysis
When reporting such discrepancies, document the experimental conditions thoroughly and consider them as complementary rather than contradictory results that may reveal important biological insights about protein structure or modifications .
Rigorous quantification of Western blot data requires systematic approaches:
Image acquisition:
Use a digital imaging system with a linear dynamic range
Avoid saturated signals that prevent accurate quantification
Capture multiple exposures to ensure signals fall within the linear range
Densitometry analysis:
Use software like ImageJ, ImageLab, or similar platforms
Define regions of interest consistently across all lanes
Subtract background using a rolling ball algorithm or nearby blank areas
Normalize target protein signals to loading control (e.g., actin, tubulin)
Statistical analysis:
Run at least three biological replicates for statistical validity
Apply appropriate statistical tests (t-test, ANOVA) based on experimental design
Report both mean values and measures of variance (standard deviation or standard error)
Validation approaches:
Create a standard curve using purified recombinant SPBC800.10c protein
Include positive controls of known concentration in each experiment
Verify linearity of signal across the range of protein amounts analyzed
Present quantitative Western blot data in bar graphs with error bars, accompanied by representative blot images showing all experimental conditions and controls .
The SPBC800.10c antibody could be instrumental in investigating chromatin reorganization during DNA damage:
ChIP-seq time course analysis:
Induce DNA damage in S. pombe using agents like methyl methanosulfonate (MMS)
Perform ChIP-seq with the SPBC800.10c antibody at multiple time points after damage
Map dynamic changes in SPBC800.10c binding across the genome during repair
Correlate with known DNA damage response elements and repair factors
Co-localization studies:
Combine ChIP with the SPBC800.10c antibody with ChIP for known DNA repair factors
Identify regions of co-occupancy that may represent repair complexes
Validate protein interactions with Co-IP under damage conditions
Chromatin accessibility analysis:
Compare chromatin accessibility (using ATAC-seq or MNase-seq) between wild-type and SPBC800.10c-deficient strains after DNA damage
Identify regions where SPBC800.10c may influence nucleosome positioning during repair
Functional rescue experiments:
This research could reveal previously unknown roles of SPBC800.10c in genome maintenance and stress response pathways.
Adapting the SPBC800.10c antibody for super-resolution microscopy requires specific optimization steps:
Antibody labeling strategies:
Direct labeling: Conjugate fluorophores (Alexa Fluor 647, Cy5) directly to the SPBC800.10c antibody
Indirect detection: Use fluorescently-labeled secondary antibodies with appropriate spectral properties
For STORM/PALM: Consider photoconvertible fluorophore conjugation
Sample preparation optimization:
Test multiple fixation methods (formaldehyde, methanol) to preserve epitope accessibility
Optimize permeabilization to ensure antibody penetration while maintaining nuclear structure
Reduce background fluorescence through careful blocking and washing steps
Imaging validation:
Confirm specificity using SPBC800.10c-deficient strains as negative controls
Compare patterns with other nuclear markers to validate subnuclear localization
Perform dual-color imaging with known interaction partners to assess co-localization at nanoscale resolution
Quantitative analysis:
Develop analysis workflows to quantify clustering, distance distributions, or co-localization
Compare patterns under different physiological conditions or cell cycle stages
This approach could reveal previously undetectable subnuclear organization patterns of SPBC800.10c and its relationship to chromatin domains or nuclear bodies .